<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=890920505535101&amp;ev=PageView&amp;noscript=1"> Skip to Content

SCOTUS Victory

Dec 11, 2020
1 min read
AAPA Team
AAPA Team
AAPA Team
Table of Contents

 

On Thursday December 10, 2020, the Supreme Court of the United States (SCOTUS) issued a unanimous (8 to 0) decision in the case Rutledge v. PCMA ruling in favor of the Petitioner, Leslie Rutledge, the Attorney General of Arkansas, and against the Pharmaceutical Care Management Association (PCMA). The PCMA is a powerful lobbying group representing the largest pharmacy benefit managers (PBMs) in the country. In Rutledge, the SCOTUS unanimously held that Arkansas’ Act 900 is not preempted by the Employment Retirement Income Security Act of 1974, more commonly known as ERISA.

 
In 2015, Arkansas enacted Act 900 to address PBM reimbursement in Arkansas that was so low many independent pharmacies and providers were losing money and, in some cases, being forced to close. Due to serious concerns regarding Arkansans’ access to critical pharmacy services, Arkansas enacted Act 900 to address PBMs’ predatory reimbursement practices. PCMA immediately challenged Act 900 arguing that it was preempted by ERISA. After the Eight Circuit held Act 900 preempted by ERISA, the SCOTUS granted Petitioner’s application for a writ of certiorari on January 10, 2020, entertained oral argument on October 6, 2020, and issued its decision today reversing the Eighth Circuit’s ruling and holding that Act 900 was not preempted. In reaching its decision, the SCOTUS noted that “Act 900 amounts to cost regulation that does not bear an impermissible connection with or reference to ERISA”, and therefore it is not preempted.

For more information regarding Rutledge v. PCMA please visit NCPA's official Rutledge v. PCMA page, where they are providing day to day updates on the case.

 

AAPA Team
Written by AAPA Team

We bring together information, news, and strategies for pharmacy owners, pharmacists, and industry professionals. Since 1996, we've been dedicated to helping independent pharmacies thrive. Built by independent pharmacists for independent pharmacists, we will continue to deliver purchasing power, business insights, and advocacy that strengthen your bottom line.

Recommended Articles

Aug 10, 2026
4 min read
6 Moves to Help Independents Finish 2026 ‘Margin Strong’
Jan 08, 2026
3 min read
CS Family Pharmacy: Starting With Workflow to Build a High-Impact Vaccination Program
May 23, 2024
2 min read
The Future of Community Pharmacy: Transformations & Innovations Post-COVID-19
May 21, 2024
2 min read
How Your Pharmacy Can Promote Heart Health
May 11, 2024
2 min read
AAPA’s “Dreier Pharmacy & Gift Shoppe”: Nominated for Health Mart Atlas Pharmacy of the Year
Nov 07, 2023
2 min read
The Power of a Pharmacy Buying Group: Staying Competitive in a Dynamic Market
Nov 01, 2023
1 min read
House Bill 4276 Boosts Independent Pharmacies and AAPA’s Vision
Oct 09, 2023
2 min read
What is an Independent Pharmacy GPO?
Apr 09, 2021
5 min read
A Pharmacist’s Vision Transforms a Community Pharmacy into A National Role Model
Dec 11, 2020
1 min read
SCOTUS Victory